Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer

Not yet recruiting

Registered drug

Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drugNo placebo

Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cabozantinib

Contact Research Centre

Non-small cell lung cancer stage IIIA+1

Not yet recruiting

Registered drugNo placebo

Study on Pembrolizumab as Maintenance Therapy for Patients with Unresectable Stage III Non-Small Cell Lung Cancer After Chemo-Radiotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Non-small cell lung cancer stage III

Not yet recruiting

Registered drugNo placebo

Study on Alectinib for Patients with ALK+ Stage III Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Alectinib

Contact Research Centre

Non-small cell lung cancer+1

Not yet recruiting

Registered drugNo placebo

Study of Niraparib and Dostarlimab for Patients with Advanced Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma with Specific Genetic Mutations

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Cystic fibrosis

Not yet recruiting

Investigational

Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Dirocaftor

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not yet recruiting

Registered drugNo placebo

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo

Italy

Participants:65+ years
Substances:Cyclophosphamide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

InvestigationalNo placebo

Study of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Amg 193

Contact Research Centre

Asthmatic crisis

Not recruiting

Investigational

Study on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Insulin-requiring type 2 diabetes mellitus

Not recruiting

Registered drugNo placebo

Study on Insulin Glargine for Patients with Type 2 Diabetes: Comparing Decentralized, Hybrid, and Standard Clinical Trial Approaches

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Insulin Glargine

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Registered drugNo placebo

Study of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Prednisone

Contact Research Centre

Find therapies in clinical trials near you – page 9

213 trials match your criteria

Non-small cell lung cancer

Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

Non-small cell lung cancer

Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Non-small cell lung cancer stage IIIA+1

Study on Pembrolizumab as Maintenance Therapy for Patients with Unresectable Stage III Non-Small Cell Lung Cancer After Chemo-Radiotherapy

Non-small cell lung cancer stage III

Study on Alectinib for Patients with ALK+ Stage III Non-Small Cell Lung Cancer

Non-small cell lung cancer+1

Study of Niraparib and Dostarlimab for Patients with Advanced Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma with Specific Genetic Mutations

Cystic fibrosis

Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

Diffuse large B-cell lymphoma refractory

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Non-small cell lung cancer

Study of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion

Asthmatic crisis

Study on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma

Non-small cell lung cancer

Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Insulin-requiring type 2 diabetes mellitus

Study on Insulin Glargine for Patients with Type 2 Diabetes: Comparing Decentralized, Hybrid, and Standard Clinical Trial Approaches

Hormone-refractory prostate cancer+1

Study of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.